OC-0562: Exploiting tumor DNA repair status and hypoxia with CP-506, a novel hypoxia-activated prodrug

Autor:	Van der Wiel, A., Marcus, D., Niemans, R., Yaromina, A., Theys, J., Mowday, A., Ashoorzadeh, A., Anderson, R., Bull, M., Abbattista, M., Heyerick, A., Guise, C., Smaill, J., Patterson, A., Dubois, L., Lambin, P.
Zdroj:	In Radiotherapy and Oncology November 2020 152 Supplement 1:S313-S314
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect